Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
China Life Insurance Co ( (HK:2628) ) has provided an update.
China Life Insurance Company Limited reported that all resolutions proposed at its second extraordinary general meeting of 2025, held in Beijing on 30 December, were duly passed by independent shareholders. Due to shareholding structure, its parent China Life Insurance (Group) Company abstained from voting on the resolutions, leaving 31.63% of the company’s issued shares, held by independent investors, eligible to vote; of these, shares representing about 30.5% of total voting rights were present through onsite and online participation, and the meeting was conducted in accordance with PRC company and securities laws and the firm’s articles of association, reinforcing governance compliance and formal shareholder backing for the approved measures.
The most recent analyst rating on (HK:2628) stock is a Buy with a HK$32.00 price target. To see the full list of analyst forecasts on China Life Insurance Co stock, see the HK:2628 Stock Forecast page.
More about China Life Insurance Co
China Life Insurance Company Limited is a major state-owned life insurer in mainland China, offering life, health, and accident insurance, annuities, and related financial services. Listed in Hong Kong and Shanghai, it plays a key role in China’s insurance and long-term savings markets, serving both individual and institutional policyholders.
Average Trading Volume: 63,629,712
Technical Sentiment Signal: Buy
Current Market Cap: HK$1289.4B
Learn more about 2628 stock on TipRanks’ Stock Analysis page.